MARCELLA MCGUFFIN: Open Payments
NPI 1891747432 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 65 payments from 11 companies in 2025. Trend: 2023 $1,052 · 2024 $1,387 · 2025 $1,131
Food & beverage: $1,131
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $279 |
| Lilly USA, LLC | 13 | $234 |
| Abbott Laboratories | 11 | $226 |
| Ascendis Pharma Endocrinology Inc | 7 | $104 |
| Corcept Therapeutics | 3 | $61 |
| Tandem Diabetes Care, Inc. | 3 | $53 |
| Amgen Inc. | 3 | $50 |
| Insulet Corporation | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Sequel Med Tech, LLC | 2 | $30 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, Ozempic, Rybelsus, JARDIANCE, Yorvipath, Korlym, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across KY — which companies pay providers there.
